Lexicon Pharmaceuticals
LXRX
LXRX
103 hedge funds and large institutions have $308M invested in Lexicon Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 23 increasing their positions, 28 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
18% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 28
22% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 23
53% less capital invested
Capital invested by funds: $662M → $308M (-$354M)
Holders
103
Holding in Top 10
2
Calls
$1.29M
Puts
$1.43M
Top Buyers
| 1 | +$7.53M | |
| 2 | +$3.57M | |
| 3 | +$1.59M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.47M |
| 5 |
Morgan Stanley
New York
|
+$841K |
Top Sellers
| 1 | -$18.6M | |
| 2 | -$9.31M | |
| 3 | -$9.2M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.55M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.21M |